Deciphera Pharmaceuticals, Inc. Accrued Liabilities and Other Liabilities
Deciphera Pharmaceuticals, Inc. had Accrued Liabilities and Other Liabilities of $60.40 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2024-05-10
- 2024-03-31: Accrued Liabilities and Other Liabilities $60.40M.
- 2023-12-31: Accrued Liabilities and Other Liabilities $70.30M.
- 2023-09-30: Accrued Liabilities and Other Liabilities $68.00M.
- 2023-06-30: Accrued Liabilities and Other Liabilities $59.45M.
| Period end | Accrued Liabilities and Other Liabilities | Accrued Liabilities and Other Liabilities as first filed |
|---|---|---|
| 2024-03-31 | $60.40M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $70.30M 10-Q · filed 2024-05-10 | |
| 2023-09-30 | $68.00M 10-Q · filed 2023-10-30 | |
| 2023-06-30 | $59.45M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $60.94M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $64.62M 10-K · filed 2024-02-07 | |
| 2022-09-30 | $59.50M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $55.21M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $65.94M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $80.77M 10-K · filed 2023-02-07 | |
| 2021-09-30 | $59.63M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $49.43M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $49.34M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $55.23M 10-K · filed 2022-02-08 | |
| 2020-09-30 | $48.94M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $37.33M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $32.23M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $38.72M 10-K · filed 2021-02-09 | |
| 2019-09-30 | $26.88M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $20.93M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $16.33M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $13.71M 10-K · filed 2020-03-09 | $14.25M 10-K · filed 2019-03-14 |
| 2018-09-30 | $11.41M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $11.79M 10-Q · filed 2018-08-07 | |
| 2017-12-31 | $9.23M 10-K · filed 2019-03-14 |